F. Behar-Cohen France

Unravelling the inflammation pathway

A. García-Layana Spain

Seeking consensus in DME management: findings from Spain

L. Kodjikian France

Key questions for managing DME in daily practice

H. Selen Kanar Turkey

Switch on, switch off: case series

Panelists:

A. Loewenstein Israel

B. Kuppermann US

F. Behar-Cohen France

A. García-Layana Spain

L. Kodjikian France

H. Selen Kanar Turkey

Discussion and Q&A

P. Keane UK

Use of swept source OCT in challenging cases of central serous chorioretinopathy

C. Hoyng Netherlands

Morphological and topographical appearance of microaneurysms on swept-source OCTA

V. Papastefanou UK

Diabetic Retinopathy & Swept Source OCTAngio

A. Gaudric France

Patterns of choroidal thickness in healthy choroid: where pachychoroid does start?

J. Eells USA

Photobiomodulation for the treatment of retinal and optic nerve disease

K. Valter Australia

From bench to bedside – photobiomodulation in preclinical studies (an update)

M. Munk Switzerland

LIGHTSITE I: clinical analysis of the safety and efficacy of photobiomodulation in subjects with dry age-related macular degeneration

B. Burton UK

LIGHTSITE II: insights from the ongoing multi-center european clinical trial

B. Bodaghi France

Non-infectious uveitis affecting the posterior segment of the eye

M. Cordero Spain

NIU-PS: the unmet patient need

C. Pavesio UK

The 001 study: ILUVIEN for the prevention of relapse in recurrent NIU-PS

R. Khoramnia Germany

ILUVIEN real world data: experience from clinical practice

Q. Nguyen USA

Lessons learned and patient pathways in NIU-PS / closing remarks

C. Orduna Spain

Experiences from 1 year navigated microsecond pulsing laser treatments in DME

N-A. Striebe Germany

Navigated microsecond pulsing treatment for central serous chorioretinopathy. A 100 cases review.

E. Di Carlo Germany

Short term efficacy and safety of navigated microsecond pulsing laser treatment in patients affected by macular edema after BRVO

J. Chhablani USA

Feasibility and study results of navigated microsecond pulsing peripheral laser treatment in diabetic retinopathy

A. Augustin Germany

Inflammatory response and cytokines in DME

P. Udaondo Spain

Prognostic and predictive biomarkers: research meets clinical practice

F. Bandello Italy

Switch reality: preventing recurrence, preserving vision

S. Sadda USA

Variability of the normal peripheral choroidal circulation

P. Stanga UK

International classification and guidelines for widefield imaging

T. Peto UK

Deep learning and artificial intelligence for diagnosing retinal disease

H. Augustin Germany

Spotlight on the angiopoietin pathway

J. Monés Spain

Clinical evidence for the role of Ang-2 in retinal diseases

R. Carvalho Portugal

The power of Stellaris Elite™ - taking performance further

E. Bali Belgium

Key learnings and surgical pearls with Vitesse™

Bausch + Lomb R&D team

How we’re raising the bar in retina innovation

R. Tadayoni France

Introduction and opening remarks

K. Al Sabti Kuwait

Go beyond 3D visualization

F. Devin France

Complex and VR surgical cases using the advanced features of the Constellation® Vision System

S. Rizzo Italy

Speed, flow, stability, access-the new HyperVit™ 20K vitrectomy Probe

M. Mura Saudi Arabia

27+® as go-to technology for challenging vitreoretinal cases

J.A. Pournaras Switzerland

Modern surgical management of vitreoretinal pathologies

N. Bechrakis Germany

Management of intraocular tumors with an advanced surgical system

A. García-Layana Spain

Welcome and introduction

F. Bandello Italy

Unmet needs in the management of nAMD

L. Kodjikian France

The future of nAMD

M. Stumpp Switzerland

DARPin - a new approach to nAMD

M. De Smet Switzerland

What´s in the pipeline for patients?

J. Monés Spain

The role of complement in geographic atrophy

U. Chakravaraty UK

Results from the FILLY phase 2 trial

I. Pearse UK

Evaluation of baseline characteristics on GA lesion progression in the FILLY trial

F.G. Holz Germany

Derby and Oaks phase 3 trials in GA

P. Stalmans Belgium

First evidence for clinical trial of 27G vs 23G surgery

E. El Rayes Egypt

How innovation is making 27G a reality

C. Mazit France

Management of retinal detachment using 27g and a prospective randomised study comparing 25G vs 27G for the management of ERM and macular holes

F. Nerinckx Belgium

First experience with a new shorter 27G vitrectomy kit

A. García-Layana Spain

A. Minnella Italy

How to manage patients at risk of AMD with STARS questionnaire

A. Tufail UK

Artificial intelligence. Where do we go from here?

C. Creuzot-Garcher France

Diabetic retinopathy and OCT-A

D. Crabb UK

And what do people with AMD see?

V. Chong UK

How retina lasers are different from each other?

A. Filloy Spain

Fovea-involving DME: reasons for the SubLiminal approach

L. Altay Germany

SubLiminal laser in CCSC management

L. Wu Costa Rica

Why SubLiminal laser should be favored vs PDT for CCSC treatment

V. Chong UK

New treatment perspectives and conclusion

A. Loewenstein Israel

Outcomes in real-world settings and therapeutic advancements

P. Campochiaro USA

Continuous delivery: A future approach to nAMD management

J-F. Korobelnik France

Exploring new boundaries of OCT-A

G. Staurenghi Italy

Next generation of ultra-widefield angiography

G. Lang Germany

Integrated diagnostic imaging maximizing your diagnostic instruments